Export Pharma Company in India | Export Pharmaceutical Company in Gujarat

Green Cross Remedies

Green Cross Remedies is one of the leading export pharmaceutical company in Gujarat. This organization has been associated with the pharma industry for the last 20 years. It is a highly qualified and devoted place that has always been asserted to a company. You are provided with world-class pharma services, high-quality, with a unique marketing strategy. Green Cross Remedies certified manufacturers of injection, tablets, capsules, suspensions & syrups, external liquids, ointments, creams, beta-lactam solutions, soaps, shampoos, eye drops, ear drops, oral sachets, external powders and cosmetics, and veterinary solutions. 

India's leading pharmaceutical Merchant distributor and export pharmaceutical company with 100% satisfied results:

• Get the availability of international quality products with Green Cross Remedies. 
• The exact execution of our orders with speedy delivery and good condition. 
• Provides the most demanding product molecules. 
• The customer gets the delivery within a promising time. 
• Focus mainly on process & quality and results: best quality with affordable cost. 
• Offering opportunities for personal and professional growth of employees and people associated with them. 
• Prioritized customer satisfaction and tries to know ideas, requirements, reviews, and suggestions from them. 
• Green Cross Remedies always value the ideas of our prime current distributors, doctors, and pharmacists for product quality, packaging, and pricing. And work according to their feedback to improve us.  

To upgrade the quality and level of the pharma solutions through continual communication with suppliers and deliver all information for customers’ needs. 

We have unique Pharma Product Range that beats out the competition and give a wider choice to select various new molecules. Green Cross commitment and dedication to consistently achieve the HIGHEST QUALITY STANDARDS has won us the trust of all fraternity.

Green Cross Remedies Have Good And Potential Market in INDIA. Green cross remedies – Leading Pcd Pharma Franchise company in India. GCR is One of the Best Pharma company in India

Now, Green cross Remedies has entered into the Lease/Loan License agreements with state-of-the-art manufacturing site for production of its products. All the Tie-up plants have modern facilities to handle global requirements Certified with WHO GMP, ISO 9001:2015 quality systems towards High Product International Quality Assurance & Environment Management System. The company has Good Financial Strength & Emerging Leadership to maintains the growth rate consistently.

Since its establishment (2003),  Green Cross has maintained the highest standards of quality control and assurance adhering to the self-enunciated SOPs (Standard Operating Procedures) for efficient and hazel-free operations. We at Green Cross Group always oblige to manufacture products which fulfill the desires of mankind & provide them full product satisfaction.

Green Cross Remedies Had Tie-up With Green Cross Hygiene-Cosmetic Products Manufacturing Unit, Nucleus Formulation (WHO-GMP Certified Non Beta Tablet/Capsule Unit), Nikol Formulation (WHO-GMP Certified Liquid Syrup Manufacturing Unit), Trivago Life science (GMP Certified Beta Powder Indictable Unit) , Sefynium Innoveda (GMP Certified Herbal Product Manufacturing Unit – All Dosage Form covered in this Herbal Unit), Nikol Healthcare (WHO-GMP, USFDA Approved Nutraceutical Products Manufacturing Unit), and Many other good Pharmaceutical Unit.

Green Cross Remedies Have Own Packing Materials Manufacturing Plants Named Swizzet International, Saffron Pet and Plastic, Green Cross Pharma Foil, Parth Flexi Pack and Balaji Corugated Box Supplier.

EXPORTER OF BRANDED AND GENERIC PHARMA PRODUCTS

Green Cross Remedies is an exporter of ethical and generic medicines worldwide. Our products are manufactured in WHO, cGMP, GLP , USFDA Compliance and ISO certified manufacturing units in Gujarat.
Our Products (Branded and Generics Formulation) exports to many countries Globally, Which includes , African & South –East Asian Countries.
Currently we are exporting different products to African & South –East Asian Countries.
We produce various dosage forms encompassing a vast range of therapeutic categories. Our formulation development team and regulatory department are focused on Latest molecules & Product Formulation.
We are the exporters of Pharmaceutical Products like Tablets, Capsule, Injactables, Sachets, Syrups, Nutritional Supplements (Dietary Products), Isabgol Products, Herbal Supplements, and Cosmetic Product etc….

Following Is Information Regarding Pharmaceutical Export of India & Gujarat.

An overview of Global Pharma Industry & India’s Role

Pharmaceutical industry globally during the year 2020 has been a bit sluggish. However, India’s Pharmaceutical exports during Fy-21, has recorded a growth of over 18%, which happens to be the highiest during the last seven years. Global market has recorded a turnover of $ 1265.2 billion during the calendar year of 2020(Source: Iquiva report on Global Medicines & usage trends) and has grown by just 1% with an incremental value of $12 bn. General grouping of different markets constituting global market is shown in the table below.

Group	$ Billion
Developed Market	959.5
Pharma Emerging ( India is a part of this)	290.8
Rest	15
Global market	1265.3

In the next Five years Global market is forecasted to grow at a CAGR of 3-4% and touch $1,600 billion by 2025, which would be an increase of around $ 350 billion in value. Pharma emerging Group is expected to grow at a CAGR of 7.4% and reach a size of $415-445 billion by 2025, i.e contributing $119-154 bn of incremental value while, the rest of the incremental value is expected from the group of developed markets despite an estimated lower growth of 3.8%. Currently India is ranked by this reputed data source as the 11th largest market and is expected to be ranked as 9th largest by 2025. Among the therapy areas it is Oncology with $167 billion & Immunology with $ 107 billion which are expected to grow at a high rate of 9-12% during the next five years. Rest of the therapies are forecasted to grow at much slower pace except Vaccines which is expected to grow at almost 15% during the next Five years. 50% of the actual defined daily doses of Medicines are used to manage chronic conditions like cardiovascular, Diabetes, respiratory and Central Nervous disorders and another 10% in Oncology. Rest is only to manage other acute conditions in Developed economies.

India Based Companies Featuring among top 20 Generic companies $ Million
Sr. No	Rank	Company	Turn Over ($ Millions)
1	6	Sun Pharma	4539
2	8	Aurobindo Pharma	3257
3	11	Cipla	2360
4	12	Dr.Reddy's Laboratories	2311
5	13	Lupin	2135
6	14	Intas	2108
7	16	Zyduscadila	1692
8	20	Glenmark	1471

India’s Pharmaceutical industry during 2020-21 has produced $40.85 billion worth of finished dosage forms of Generics, out of which $ 18.85 billion has been exported and is self-sufficient as far as generic formulations are concerned. However, India Imported Bulk Drug & Drug Intermediates (Mostly Lower intermediates) to a tune of $ 3841 million.

India is the largest exclusive generic exporter in the world.

India’s Pharma Exports by Country

• India has exported Pharmaceuticals to 202 Destinations during Fy-21
• Exports to Only USAwhich contributes over 31.6% of the total is over $ 1billion
• Exports to 52 destinations are over $ 100 million.
• Exports to 15 Destinations have grown over 30%.
• India’s Accreditations From Various regulatory agencies

Gujarat is known as the Pharmaceutical Hub of India. 

Here are the numbers we are talking about!

•  6% of India’s Territory
•  1/3 Of India’s Pharma Production
•  28% Of India’s Pharma Export
•  4776 – Licensed Pharma Products Manufacturing Units
•  700 – WHO-GMP compliance Units.
•  130 – USFDA Registered Pharma Production Unit  

Exports of Pharmaceuticals in Gujarat

Gujarat is biggest exporter of pharma products in India and accounts for 19.5% of India’s pharma exports in FY21*

Gujarat witnessed Y-O-Y growth of 11% in drug exports in FY21*

[*Fig. till feb.-2021- Note: Fig and info from Pharmexcil]